PPARalpha is a key regulator of hepatic FGF21.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 17601491
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of Fibric Acid Derivatives in the Management of Risk Factors for Coronary Heart Disease

  2012cited by this paper
• The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.

  2007cited by this paper
• Molecular determinants of FGF‐21 activity—synergy and cross‐talk with PPARγ signaling

  2007cited by this paper
• Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man

  2006cited by this paper
• Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways.

  2006cited by this paper
• FGF-21 as a novel metabolic regulator.

  2005cited by this paper
• The role of fibrates in managing hyperlipidemia: Mechanisms of action and clinical efficacy

  2004cited by this paper
• Peroxisome proliferator-activated receptor alpha target genes.

  2004cited by this paper
• Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.

  2000cited by this paper
• Identification of a novel FGF, FGF-21, preferentially expressed in the liver.

  2000cited by this paper
• Peroxisome proliferator-activated receptor alpha (PPARalpha) and agonist inhibit cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription.

  2000cited by this paper
• Fibrates increase human REV-ERBalpha expression in liver via a novel peroxisome proliferator-activated receptor response element.

  1999cited by this paper
• Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.

  1999cited by this paper
• A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders.

  1999cited by this paper
• Use of human hepatocytes to study P450 gene induction.

  1996cited by this paper
• Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: Reduced activity of cholesterol 7α‐hydroxylase

  1995cited by this paper
• Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

  1995cited by this paper

• Epigenetic orchestrator and drug enhancer: dual roles of butyrate in regulating post-translational modification and optimizing therapeutic delivery

  2025cites this paper
• Pine nut oil as a functional alternative to corn oil: Process selection, provenance profiling, and multi-omics evidence of lipid-lowering efficacy in Western-diet mice.

  2025cites this paper
• Effect of Fenofibrate on Markers of Gut Barrier Function in Dogs With Naturally Occurring Diabetes Mellitus

  2025cites this paper
• Role of FGF21 in Heart Failure: Molecular Insights and Therapeutic Implications.

  2025cites this paper
• Hepatic FGF21 Deletion Improves Glucose Metabolism, Alters Lipogenic and Chrna4 Gene Expression, and Enhances Telomere Maintenance in Aged Female Mice

  2025cites this paper
• A nano-pesticide with low toxicity for earthworms obtained by immobilizing avermectin onto Mg/Al layered double hydroxides.

  2025cites this paper
• Research progress on the role of FGF21 in insulin resistance

  2025cites this paper
• Molecular hydrogen mitigates acetaminophen-induced liver injury and enhances the effects of N-acetylcysteine in diabetic mice.

  2025cites this paper
• Fibroblast growth factor 15 overexpression and combined peroxisome proliferator–activated receptor α activation attenuates metabolic dysfunction–associated steatohepatitis progression in mice

  2025cites this paper
• Chinese medicine formulation Mailuoning attenuates high-fat diet-induced obesity by regulating thermogenesis through activating the peroxisome proliferator-activated receptor α/fibroblast growth factor 21 axis.

  2025cites this paper
• A scoping review on the possible immunometabolic properties of the furan fatty acid metabolite 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid.

  2025cites this paper
• FGF21 mediating sex dependent response to dietary macronutrients.

  2024cites this paper
• Mitochondrial complex I inhibition triggers NAD+-independent glucose oxidation via successive NADPH formation, “futile” fatty acid cycling, and FADH2 oxidation

  2024cites this paper
• Effects of angiotensin receptor-neprilysin inhibitor on ketone body metabolism in pre-heart failure/heart failure patients

  2024cites this paper
• Exploring endocrine FGFs - structures, functions and biomedical applications.

  2024cites this paper
• Protein Restriction in Metabolic Health: Lessons from Rodent Models

  2024cites this paper
• Lipid sensing by PPARα: Role in controlling hepatocyte gene regulatory networks and the metabolic response to fasting.

  2024cites this paper
• FGF21 and its underlying adipose tissue-liver axis inform cardiometabolic burden and improvement in obesity after metabolic surgery

  2024cites this paper
• Madecassoside modulates lipid metabolism in visceral adipocytes: exploring the browning, lipolysis, and lipogenesis mechanisms for potential obesity treatment.

  2024cites this paper
• Brown and Beige Adipose Tissue: One or Different Targets for Treatment of Obesity and Obesity-Related Metabolic Disorders?

  2024cites this paper
• Exercise enhances hepatic mitochondrial structure and function while preventing endoplasmic reticulum stress and metabolic dysfunction-associated steatotic liver disease in mice fed a high-fat diet.

  2024cites this paper
• Circadian Regulation of Endocrine Fibroblast Growth Factors on Systemic Energy Metabolism

  2024cites this paper
• Hepatic function of glucagon-like peptide-1 and its based diabetes drugs

  2024cites this paper
• Role of liver FGF21-KLB signaling in ketogenic diet-induced amelioration of hepatic steatosis

  2024cites this paper
• Fibroblast growth factor 21.

  2024cites this paper
• Hepatocyte Period 1 dictates oxidative substrate selection independent of the core circadian clock

  2024cites this paper
• FGF21 upregulation by hepatitis C virus via the eIF2α-ATF4 pathway: implications for interferon signaling suppression and TRIM31-mediated TSC degradation

  2024cites this paper
• FGF21 and its underlying adipose tissue-liver axis inform cardiometabolic burden and improvement in obesity after metabolic surgery

  2024cites this paper
• Decoding FGF/FGFR Signaling: Insights into Biological Functions and Disease Relevance

  2024cites this paper
• Targeting nuclear receptors for NASH/MASH: From bench to bedside

  2024cites this paper
• The role of FGF21 in the interplay between obesity and non-alcoholic fatty liver disease: a narrative review

  2024cites this paper
• Molecular origin and biological effects of exercise mimetics

  2023cites this paper
• Berberine protects mice against type 2 diabetes by promoting PPARγ-FGF21-GLUT2-regulated insulin sensitivity and glucose/lipid homeostasis.

  2023cites this paper
• The Role of the FGF19 Family in the Pathogenesis of Gestational Diabetes: A Narrative Review

  2023cites this paper
• Effects of central FGF21 infusion on the glucose homeostasis in rats (brain–pancreas axis)

  2023cites this paper
• Novel Approaches to the Management of Diabetes Mellitus in Patients with Coronary Artery Disease.

  2023cites this paper
• Fibroblast growth factor-21 (FGF21) analogs as possible treatment options for diabetes mellitus in veterinary patients

  2023cites this paper
• Fibroblast growth factor 21 in metabolic syndrome

  2023cites this paper
• Effects of body composition and liver function after long-term pemafibrate treatment on dyslipidemia-associated non-alcoholic fatty liver disease

  2023cites this paper
• Hepatokine‐based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patients

  2023cites this paper
• Hepatocyte-Secreted Autotaxin Exacerbates Nonalcoholic Fatty Liver Disease Through Autocrine Inhibition of the PPARα/FGF21 Axis

  2022cites this paper
• Crosstalk between CYP2E1 and PPARα substrates and agonists modulate adipose browning and obesity

  2022cites this paper
• Alcoholic fatty liver is blunted by rFGF21 administration in mice lacking adipose FGFR1: The role of FGF21 in PPARα-mediated regulation of adipose tissue mass.

  2022cites this paper
• Zonated leucine sensing by Sestrin-mTORC1 in the liver controls the response to dietary leucine

  2022cites this paper
• The Role of Nutraceutical Supplements, Monacolin K and Astaxanthin, and Diet in Blood Cholesterol Homeostasis in Patients with Myopathy

  2022cites this paper
• Selective PPARδ agonist seladelpar suppresses bile acid synthesis by reducing hepatocyte CYP7A1 via the fibroblast growth factor 21 signaling pathway

  2022cites this paper
• Myeloid p38 activation maintains macrophage–liver crosstalk and BAT thermogenesis through IL‐12–FGF21 axis

  2022cites this paper
• Endocrine Fibroblast Growth Factors in Relation to Stress Signaling

  2022cites this paper
• Bicistronic reporter mice for monitoring of Fgf21 expression.

  2022cites this paper
• The Nuanced Metabolic Functions of Endogenous FGF21 Depend on the Nature of the Stimulus, Tissue Source, and Experimental Model

  2022cites this paper
• Fibroblast Growth Factor 21 Facilitates the Homeostatic Control of Feeding Behavior

  2022cites this paper
• Intermittent Fasting as Possible Treatment for Heart Failure.

  2022cites this paper
• AdipoRon exerts opposing effects on insulin sensitivity via fibroblast growth factor 21–mediated time-dependent mechanisms

  2022cites this paper
• Curcumin and Weight Loss: Does It Work?

  2022influential citation
• Hepatic Hedgehog Signaling Participates in the Crosstalk between Liver and Adipose Tissue in Mice by Regulating FGF21

  2022cites this paper
• Nuclear Receptors in Energy Metabolism.

  2022cites this paper
• Seed- and leaf-based expression of FGF21-transferrin fusion proteins for oral delivery and treatment of non-alcoholic steatohepatitis

  2022cites this paper
• Fibroblast Growth Factor-Based Pharmacotherapies for the Treatment of Obesity-Related Metabolic Complications.

  2022cites this paper
• Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21–AMPK pathway in mice fed a high fat diet

  2022cites this paper
• The potential function and clinical application of FGF21 in metabolic diseases

  2022cites this paper
• Browning of the white adipose tissue regulation: new insights into nutritional and metabolic relevance in health and diseases

  2022cites this paper
• A Lifestyle/Nutraceutical Program for Minimizing Colorectal Cancer Risk by Opposing β-Catenin Activity in Colonic Epithelium

  2021cites this paper
• Skeletal Muscle and Bone – Emerging Targets of Fibroblast Growth Factor-21

  2021cites this paper
• IMPACT OF ETHANOL INTAKE ON FIBROBLAST GROWTH FACTOR 21 AND BILE ACID METABOLISM

  2021cites this paper
• (+)-Dehydrovomifoliol Alleviates Oleic Acid-Induced Lipid Accumulation in HepG2 Cells via the PPARα–FGF21 Pathway

  2021cites this paper
• Insights into energy balance dysregulation from a mouse model of methylmalonic aciduria

  2021cites this paper
• Beyond the Liver: Liver-Eye Communication in Clinical and Experimental Aspects

  2021cites this paper
• The Saga of Endocrine FGFs

  2021influential citation
• Hepatic CPT1A Facilitates Liver-Adipose Cross-Talk via Induction of FGF21 in Mice.

  2021cites this paper
• Fibroblast growth factor 21 in dairy cows: current knowledge and potential relevance

  2021cites this paper
• Changes in PGC-1α-Dependent Mitochondrial Biogenesis Are Associated with Inflexible Hepatic Energy Metabolism in the Offspring Born to Dexamethasone-Treated Mothers

  2021cites this paper
• Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature.

  2021cites this paper
• LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in obese adults with modest hypertriglyceridemia.

  2021cites this paper
• PPARα agonist WY-14,643 induces adipose atrophy and fails to blunt chronic ethanol-induced hepatic fat accumulation in mice lacking adipose FGFR1.

  2021cites this paper
• Estrogen-Wnt signaling cascade regulates expression of hepatic fibroblast growth Factor 21.

  2021cites this paper
• Transmembrane G protein-coupled receptor 5 signaling stimulates fibroblast growth factor 21 expression concomitant with up-regulation of the transcription factor nuclear receptor Nr4a1.

  2021cites this paper
• Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice

  2021cites this paper
• Starvation‐induced transcription factor CREBH negatively governs body growth by controlling GH signaling

  2021cites this paper
• Changes in hepatic triglyceride content with the activation of ER stress and increased FGF21 secretion during pregnancy

  2021cites this paper
• Pemafibrate Prevents Retinal Dysfunction in a Mouse Model of Unilateral Common Carotid Artery Occlusion

  2021cites this paper
• Liver-Specific Nonviral Gene Delivery of Fibroblast Growth Factor 21 Protein Expression in Mice Regulates Body Mass and White/Brown Fat Respiration

  2021cites this paper
• The role of increased FGF21 in VLDL-TAG secretion and thermogenic gene expression in mice under protein malnutrition.

  2021cites this paper
• Th2 Cytokines Increase the Expression of Fibroblast Growth Factor 21 in the Liver

  2021cites this paper
• Current understanding and controversies on the clinical implications of fibroblast growth factor 21

  2020cites this paper
• Hepatic FGF21 is Under the Regulation of the Canonical Wnt Signaling Pathway by Yasaman Badakhshi A thesis submitted in conformity with the requirements

  2020influential citation
• Fatty Acid Desaturase 1 Influences Hepatic Lipid Homeostasis by Modulating the PPARα‐FGF21 Axis

  2020cites this paper
• FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases

  2020cites this paper
• Triclosan leads to dysregulation of the metabolic regulator FGF21 exacerbating high fat diet-induced nonalcoholic fatty liver disease

  2020cites this paper
• FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human

  2020cites this paper
• K27Q/K29Q mutations in sphingosine kinase 1 attenuate high-fat diet induced obesity and altered glucose homeostasis in mice

  2020cites this paper
• Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administration.

  2020cites this paper
• Non-alcoholic fatty liver disease: a metabolic burden promoting atherosclerosis.

  2020cites this paper
• The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients

  2020cites this paper
• NAD+/sirtuin metabolism is enhanced in response to cold‐induced changes in lipid metabolism in mouse liver

  2020cites this paper
• FGF21 Mimics a Fasting-Induced Metabolic State and Increases Appetite in Zebrafish

  2020cites this paper
• The PPAR pan-agonist tetradecylthioacetic acid promotes redistribution of plasma cholesterol towards large HDL

  2020cites this paper
• miR-22 inhibition reduces hepatic steatosis via FGF21 and FGFR1 induction

  2020cites this paper
• Assessment of the role of FGF15 in mediating the metabolic outcomes of murine Vertical Sleeve Gastrectomy (VSG).

  2020cites this paper
• Targeted DNA demethylation of the Fgf21 promoter by CRISPR/dCas9-mediated epigenome editing

  2020cites this paper
• PPARα and NCOR/SMRT corepressor network in liver metabolic regulation

  2020cites this paper